Hiroki Yukami Selected Research

Hiroki Yukami Research Topics

7	Neoplasms (Cancer) 09/2022 - 03/2021
4	Stomach Neoplasms (Stomach Cancer) 09/2023 - 10/2019
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2021
2	Colonic Neoplasms (Colon Cancer) 09/2022 - 07/2021
1	Neutropenia 09/2023
1	Febrile Neutropenia 09/2023
1	Esophageal Squamous Cell Carcinoma 08/2022
1	Lymphatic Metastasis 04/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 03/2021

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2021 - 10/2019
2	Cisplatin (Platino)FDA LinkGeneric 09/2023 - 10/2019
2	Irinotecan (Camptosar)FDA LinkGeneric 09/2023 - 03/2021
2	Cetuximab (Erbitux)FDA Link 09/2022 - 01/2020
2	Circulating Tumor DNAIBA 04/2022 - 07/2021
2	Capecitabine (Xeloda)FDA Link 07/2021 - 03/2021
1	S 1 (combination)IBA 09/2023
1	Bevacizumab (Avastin)FDA Link 09/2022
1	Epidermal Growth Factor (EGF)IBA 09/2022
1	Panitumumab (Vectibix)FDA Link 09/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	pembrolizumabIBA 01/2022
1	regorafenibIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	lenvatinibIBA 01/2022
1	AntibodiesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	NivolumabIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	trifluridine tipiracil drug combinationIBA 07/2021
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	XELOXIBA 03/2021
1	Leucovorin (Folinic Acid)FDA Link 03/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2021

2	Adjuvant Chemotherapy 01/2023 - 07/2021
2	Therapeutics 09/2022 - 07/2021
2	Immunotherapy 01/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 09/2023
1	Chemoradiotherapy 08/2022
1	Esophagectomy 08/2022
1	Aftercare (After-Treatment) 04/2022
1	Lymph Node Excision (Lymph Node Dissection) 04/2022
1	Neoadjuvant Therapy 03/2021